Can Relmada’s fast-acting pill for major depressive disorder compete in a crowded market?
Relmada’s investigational pill for major depressive disorder (MDD) could face tough competition with entrenched generic SSRIs and novices like J&J’s…
By
Market Data
Latest in
Market Data
An oral pill for alcohol abuse vies to enter a quickly evolving market
Adial Pharmaceuticals CEO William Stilley discusses the challenges of bringing an alcohol abuse disorder therapy to market.
By